Core Scientific Analyst Price Targets

Wall Street analyst price targets and consensus rating for Core Scientific (CORZ).

Price Target Range — 11 Quarters

Analyst Consensus — 23 Analysts

1S.Buy

18Buy

4Hold

Consensus RatingBuy# Analysts23Avg. Consensus PT$28Upside to Avg. PT+90.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 16, 2026	Cantor Fitzgerald	Brett Knoblauch	PT Cut	Overweight	$39→$30
Oct 15, 2026	Canaccord Genuity	Joseph Vafi	Maintained	Buy	$36
Oct 15, 2026	BTIG	Gregory Lewis	Maintained	Buy	$38
Oct 14, 2026	Cantor Fitzgerald	Brett Knoblauch	Maintained	Overweight	$39
Sep 23, 2026	UBS	Ryan Gravett	Initiate	Buy	$24
Sep 21, 2026	Rothschild & Co	Alex Haissl	Initiate	Neutral	$16
Sep 17, 2026	Wells Fargo	Eric Luebchow	Initiate	Overweight	$28
Aug 3, 2026	B. Riley Securities	Lucas Pipes	PT Raise	Buy	$33→$42
Jul 30, 2026	Keefe, Bruyette & Woods	Stephen Glagola	Upgrade	Market Perform→Outperform	$25→$28
Jul 29, 2026	Macquarie	Paul Golding	PT Raise	Outperform	$35→$38
Jul 29, 2026	Needham	John Todaro	PT Raise	Buy	$29→$35
Jul 29, 2026	Canaccord Genuity	Joseph Vafi	PT Raise	Buy	$30→$36
Jul 28, 2026	Needham	John Todaro	Maintained	Buy	$29
Jul 28, 2026	BTIG	Gregory Lewis	Maintained	Buy	$38
Jun 25, 2026	BTIG	Gregory Lewis	PT Raise	Buy	$33→$38
Jun 16, 2026	Freedom Broker	Paul Meeks	Initiate	Hold	$33
May 27, 2026	B. Riley Securities	Lucas Pipes	PT Raise	Buy	$30→$33
May 14, 2026	Jefferies	Jonathan Petersen	PT Raise	Buy	$24→$37
May 13, 2026	BTIG	Gregory Lewis	PT Raise	Buy	$23→$33
May 7, 2026	Macquarie	Paul Golding	PT Raise	Outperform	$28→$35

Analyst Ratings News

PRO
Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

Cantor Fitzgerald analyst Brett Knoblauch maintains Core Scientific (NASDAQ:CORZ) with a Overweight and lowers the price target from $39 to $30.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target

BTIG analyst Gregory Lewis reiterates Core Scientific (NASDAQ:CORZ) with a Buy and maintains $38 price target.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

Cantor Fitzgerald analyst Brett Knoblauch reiterates Core Scientific (NASDAQ:CORZ) with a Overweight and maintains $39 price target.

Benzinga Newsdesk

Hut 8, TeraWulf, Applied Digital: UBS Sees at Least 30% Upside

UBS rates five AI data center operators Buy, citing lease growth and stronger tenants; TeraWulf, Hut 8 and Applied Digital lead upside.

Erica Kollmann

PRO
UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

UBS analyst Ryan Gravett initiates coverage on Core Scientific (NASDAQ:CORZ) with a Buy rating and announces Price Target of $24.

Benzinga Newsdesk

PRO
Rothschild & Co Initiates Coverage On Core Scientific with Neutral Rating, Announces Price Target of $16

Rothschild & Co analyst Alex Haissl initiates coverage on Core Scientific (NASDAQ:CORZ) with a Neutral rating and announces Price Target of $16.

Benzinga Newsdesk

Core Scientific Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Core Scientific Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

PRO
BTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

Hut 8, TeraWulf, Applied Digital: UBS Sees at Least 30% Upside

PRO
UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

PRO
Rothschild & Co Initiates Coverage On Core Scientific with Neutral Rating, Announces Price Target of $16

People Also Watch

People Also Watch

Core Scientific Inc

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

Core Scientific Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

PROBTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target

PROCantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

Hut 8, TeraWulf, Applied Digital: UBS Sees at Least 30% Upside

PROUBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

PRORothschild & Co Initiates Coverage On Core Scientific with Neutral Rating, Announces Price Target of $16

People Also Watch

People Also Watch

PRO
Cantor Fitzgerald Maintains Overweight on Core Scientific, Lowers Price Target to $30

PRO
BTIG Reiterates Buy on Core Scientific, Maintains $38 Price Target

PRO
Cantor Fitzgerald Reiterates Overweight on Core Scientific, Maintains $39 Price Target

PRO
UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

PRO
Rothschild & Co Initiates Coverage On Core Scientific with Neutral Rating, Announces Price Target of $16